清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Pharmacokinetic and Pharmacodynamic Interactions Between Henagliflozin, a Novel Selective SGLT-2 Inhibitor, and Warfarin in Healthy Chinese Subjects

最大值 医学 华法林 药代动力学 药效学 药理学 内科学 心房颤动
作者
Xuejun He,Gege Liu,Xinyan Chen,Yaqin Wang,Ran Liu,Changmao Wang,Yunzhe Huang,Jie Shen,Yuanwei Jia
出处
期刊:Clinical Therapeutics [Elsevier BV]
卷期号:45 (7): 655-661 被引量:17
标识
DOI:10.1016/j.clinthera.2023.06.002
摘要

While controlling blood glucose, patients with diabetes and abnormal coagulation should be treated with positive anticoagulation because the hypercoagulable state of their blood is the primary cause of macroangiopathy. The goal of this study was to evaluate the pharmacokinetic and pharmacodynamic (PK/PD) interactions between henagliflozin, a novel selective sodium-glucose cotransporter 2 inhibitor, and warfarin in healthy subjects.This single-center, open-label, single-arm clinical study was conducted in 16 healthy male Chinese subjects. According to the study protocol, the PK properties of henagliflozin 10 mg/d and warfarin 5 mg/d were collected and tabulated in accordance with sampling time. All study drugs were given with once-daily administration. Subjects were monitored for adverse reactions and their severity, outcomes, and relationship to study drug. This influences of warfarin on the PK properties of henagliflozin (Cmax,ss and AUCτ,ss), the effects of henagliflozin on the PK properties of warfarin (Cmax, AUC0-t, and AUC0-∞), and the influences of henagliflozin on the PD properties of warfarin (PTmax, PTAUC, INRmax, and INRAUC) were evaluated.The geometric mean ratios (GMRs; 90% CIs) of henagliflozin Cmax,ss and AUCτ,ss were 101.75% (96.11%-107.72%) and 102.21% (100.04%-104.42%), respectively. The GMRs (90% CIs) of S- and R-warfarin Cmax, AUC0-t, and AUC0-∞ were as follows: Cmax, 114.31% (106.30%-122.91%) and 115.09% (109.46%-121.01%), respectively; AUC0-t, 120.15% (116.71%-123.69%) and 119.01% (116.32%-121.76%); and AUC0-∞, 120.81% (117.17%-124.58%) and 121.94% (118.90%-125.05%). The GMRs (90% CIs) of warfarin PTmax and PTAUC were 92.73% (91.25%-94.22%) and 97.42% (96.61%-98.24%). The GMRs (90% CIs) of warfarin INRmax and INRAUC were 92.66% (91.17%-94.17%) and 97.36% (96.52%-98.21%). A total of 32 cases of mild adverse events were reported, and were recovered/resolved. There were no serious adverse events reported.No significant clinically relevant effects on the PK/PD properties of henagliflozin or warfarin were found with coadministration of the two drugs in these healthy male Chinese subjects. Based on these findings, it is expected that henagliflozin and warfarin can be used in combination without dose adjustment. Chinadrugtrials.org.cn identifier: CTR20190240.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小清完成签到,获得积分10
7秒前
Aaron完成签到,获得积分10
26秒前
31秒前
38秒前
桐桐的应助被葛力采纳,获得10
46秒前
脑洞疼的应助被矢思然采纳,获得10
46秒前
1分钟前
李爱国的应助被搞怪的方盒采纳,获得30
1分钟前
1分钟前
1分钟前
1分钟前
1分钟前
烟花的应助被开朗的尔蝶采纳,获得10
1分钟前
1分钟前
1分钟前
1分钟前
幸福丹蝶完成签到,获得积分10
1分钟前
1分钟前
1分钟前
2分钟前
叫啥好呢完成签到 ,获得积分10
2分钟前
clairewen完成签到,获得积分10
2分钟前
2分钟前
2分钟前
3分钟前
3分钟前
3分钟前
矢思然发布了新的文献求助10
3分钟前
3分钟前
葛力发布了新的文献求助10
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
3分钟前
4分钟前
NN的应助被萧雨墨采纳,获得10
4分钟前
123完成签到 ,获得积分10
4分钟前
4分钟前
4分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Sex, Aging, and Death in a Medieval Medical Compendium: Trinity College Cambridge MS R.14.52, Its Texts, Language, and Scribe 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
基于界面调控的高效湿气发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8190190
求助须知:如何正确求助?哪些是违规求助? 9577282
关于积分的说明 21852326
捐赠科研通 7788645
什么是DOI,文献DOI怎么找? 3436298
关于科研通互助平台的介绍 2560076
邀请新用户注册赠送积分活动 2482902